Loading…

Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides

Introduction Proteus mirabilis bacilli play an important role in human urinary tract infections, bacteremia, and rheumatoid arthritis. The authors previously studied human complement C3 conversion by smooth-form P. mirabilis O10, O23, O30, and O43 lipopolysaccharides (LPSs) and showed that smooth Pr...

Full description

Saved in:
Bibliographic Details
Published in:Archivum Immunologiae et Therapiae Experimentalis 2009-10, Vol.57 (5), p.383-391
Main Authors: Kaca, Wiesław, Arabski, Michał Ph.D, Fudała, Rafał, Holmström, Eva, Sjöholm, Anders, Weintraub, Andrej, Futoma-Kołoch, Bożena, Bugla-Płoskońska, Gabriela, Doroszkiewicz, Włodzimierz
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c543t-994651401add656210f29861ae2706fa0457a1bb405f0e76b5b0ea6934e5bf0a3
cites cdi_FETCH-LOGICAL-c543t-994651401add656210f29861ae2706fa0457a1bb405f0e76b5b0ea6934e5bf0a3
container_end_page 391
container_issue 5
container_start_page 383
container_title Archivum Immunologiae et Therapiae Experimentalis
container_volume 57
creator Kaca, Wiesław
Arabski, Michał Ph.D
Fudała, Rafał
Holmström, Eva
Sjöholm, Anders
Weintraub, Andrej
Futoma-Kołoch, Bożena
Bugla-Płoskońska, Gabriela
Doroszkiewicz, Włodzimierz
description Introduction Proteus mirabilis bacilli play an important role in human urinary tract infections, bacteremia, and rheumatoid arthritis. The authors previously studied human complement C3 conversion by smooth-form P. mirabilis O10, O23, O30, and O43 lipopolysaccharides (LPSs) and showed that smooth Proteus LPSs fragmented C3 in a dose- and time-dependent manner. In the present study, one smooth P. mirabilis S1959 and its two polysaccharide-truncated LPSs isolated from an R mutant strain were used to study the C3 conversion. Materials and Methods The conversion of C3 to C3c by smooth and rough P. mirabilis LPSs was studied by capture ELISA and crossed immunoelectrophoresis. Proteins isolated from the outer membrane were analyzed by discontinuous sodium dodecyl sulfate gel electrophoresis. Results The smooth P. mirabilis S1959 (O3) strain was resistant to the bactericidal activity of human serum, in contrast to the Ra and Re mutant strains. The presence of an exposed core oligosaccharide in R110 LPS was not sufficient to protect the strain from serum-dependent killing. In addition to LPS structure, the outer-membrane proteins may also play roles in protecting the smooth P. mirabilis S1959 (O3) strain from the bactericidal action of serum. It was shown that the Ra P. mirabilis R110 and the Re P. mirabilis R45 mutants possess very different OMP compositions from that of the P. mirabilis S 1959 strain. Conclusion Regardless of the complement resistance of the P. mirabilis strains, the S1959, R110, and R45 LPSs fragmented C3 and induced C3c neo-antigen exposure. The use of complement-deficient human serum allows the conclusion that the Re-type P. mirabilis R45 LPS fragmented C3 by the antibody-independent classical pathway.
doi_str_mv 10.1007/s00005-009-0043-8
format article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_556241</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67606498</sourcerecordid><originalsourceid>FETCH-LOGICAL-c543t-994651401add656210f29861ae2706fa0457a1bb405f0e76b5b0ea6934e5bf0a3</originalsourceid><addsrcrecordid>eNp9kV2L1TAQhoMo7tnVH-CNFi-8q07afDSXsqyucEBBD3gXknZ6Tta2qUmrnH9vSssuCJowJGSeeZPMS8gLCm8pgHwXIQ2eA6gUrMyrR2RHhaA5U1Q-JruUZTkI9f2CXMZ4tzCcsqfkgioJUhZ0Rw63c2-GrPb92GGPw5SZenK_zOT8kNlzFnvvp1NmhiYLfj6esi_BTzjHrHfBWNe5mHVu9KPvztHU9ckE12B8Rp60pov4fFuvyOHDzbfr23z_-eOn6_f7vOasnHKlmEgPAmqaRnBRUGgLVQlqsJAgWgOMS0OtZcBbQCkst4BGqJIhty2Y8orkq278jeNs9Rhcb8JZe-P0dvQj7VDzpM5o4vf_5Lt5TGFTLAUNpqtESTW3SDVrS9S24kbz2tYlb0RVNWWSe7PKjcH_nDFOunexxq4zA_o5aiEFCKaqBL7-C7zzcxhSa3QlFVQqtSFBdIXq4GMM2N4_j4Je_Nar3zr5rRcv9SL8chOebY_NQ8VmcAKK7ccpNRwxPNz8P9VXa1FrvDbH4KI-fC2AlkCFLEWafwAcb7-J</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>879089651</pqid></control><display><type>article</type><title>Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides</title><source>Springer Link</source><creator>Kaca, Wiesław ; Arabski, Michał Ph.D ; Fudała, Rafał ; Holmström, Eva ; Sjöholm, Anders ; Weintraub, Andrej ; Futoma-Kołoch, Bożena ; Bugla-Płoskońska, Gabriela ; Doroszkiewicz, Włodzimierz</creator><creatorcontrib>Kaca, Wiesław ; Arabski, Michał Ph.D ; Fudała, Rafał ; Holmström, Eva ; Sjöholm, Anders ; Weintraub, Andrej ; Futoma-Kołoch, Bożena ; Bugla-Płoskońska, Gabriela ; Doroszkiewicz, Włodzimierz</creatorcontrib><description>Introduction Proteus mirabilis bacilli play an important role in human urinary tract infections, bacteremia, and rheumatoid arthritis. The authors previously studied human complement C3 conversion by smooth-form P. mirabilis O10, O23, O30, and O43 lipopolysaccharides (LPSs) and showed that smooth Proteus LPSs fragmented C3 in a dose- and time-dependent manner. In the present study, one smooth P. mirabilis S1959 and its two polysaccharide-truncated LPSs isolated from an R mutant strain were used to study the C3 conversion. Materials and Methods The conversion of C3 to C3c by smooth and rough P. mirabilis LPSs was studied by capture ELISA and crossed immunoelectrophoresis. Proteins isolated from the outer membrane were analyzed by discontinuous sodium dodecyl sulfate gel electrophoresis. Results The smooth P. mirabilis S1959 (O3) strain was resistant to the bactericidal activity of human serum, in contrast to the Ra and Re mutant strains. The presence of an exposed core oligosaccharide in R110 LPS was not sufficient to protect the strain from serum-dependent killing. In addition to LPS structure, the outer-membrane proteins may also play roles in protecting the smooth P. mirabilis S1959 (O3) strain from the bactericidal action of serum. It was shown that the Ra P. mirabilis R110 and the Re P. mirabilis R45 mutants possess very different OMP compositions from that of the P. mirabilis S 1959 strain. Conclusion Regardless of the complement resistance of the P. mirabilis strains, the S1959, R110, and R45 LPSs fragmented C3 and induced C3c neo-antigen exposure. The use of complement-deficient human serum allows the conclusion that the Re-type P. mirabilis R45 LPS fragmented C3 by the antibody-independent classical pathway.</description><identifier>ISSN: 0004-069X</identifier><identifier>EISSN: 1661-4917</identifier><identifier>DOI: 10.1007/s00005-009-0043-8</identifier><identifier>PMID: 19707721</identifier><language>eng</language><publisher>Basel: Basel : SP Birkhäuser Verlag Basel</publisher><subject>Bacteria ; Bacterial Outer Membrane Proteins - immunology ; Bacterial Outer Membrane Proteins - isolation &amp; purification ; Bacteriology ; Basic Medicine ; Biomedical and Life Sciences ; Biomedicine ; complement ; Complement Activation - drug effects ; Complement Activation - immunology ; Complement C3 - immunology ; Complement System Proteins - immunology ; Humans ; Immunologi inom det medicinska området ; Immunology ; Immunology in the medical area ; lipopolysaccharide ; Lipopolysaccharides - immunology ; Lipopolysaccharides - pharmacology ; Medical and Health Sciences ; Medicin och hälsovetenskap ; Medicinska och farmaceutiska grundvetenskaper ; Microbial Sensitivity Tests ; Microbiology in the medical area ; Mikrobiologi inom det medicinska området ; Original Article ; outer-membrane ; outer-membrane protein ; Pharmacology/Toxicology ; protein ; Proteins ; Proteus Infections - immunology ; Proteus mirabilis ; Proteus mirabilis - chemistry ; Proteus mirabilis - immunology ; Serum - chemistry ; Serum - immunology</subject><ispartof>Archivum Immunologiae et Therapiae Experimentalis, 2009-10, Vol.57 (5), p.383-391</ispartof><rights>L. Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland 2009</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c543t-994651401add656210f29861ae2706fa0457a1bb405f0e76b5b0ea6934e5bf0a3</citedby><cites>FETCH-LOGICAL-c543t-994651401add656210f29861ae2706fa0457a1bb405f0e76b5b0ea6934e5bf0a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19707721$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://lup.lub.lu.se/record/1476805$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:119264790$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Kaca, Wiesław</creatorcontrib><creatorcontrib>Arabski, Michał Ph.D</creatorcontrib><creatorcontrib>Fudała, Rafał</creatorcontrib><creatorcontrib>Holmström, Eva</creatorcontrib><creatorcontrib>Sjöholm, Anders</creatorcontrib><creatorcontrib>Weintraub, Andrej</creatorcontrib><creatorcontrib>Futoma-Kołoch, Bożena</creatorcontrib><creatorcontrib>Bugla-Płoskońska, Gabriela</creatorcontrib><creatorcontrib>Doroszkiewicz, Włodzimierz</creatorcontrib><title>Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides</title><title>Archivum Immunologiae et Therapiae Experimentalis</title><addtitle>Arch. Immunol. Ther. Exp</addtitle><addtitle>Arch Immunol Ther Exp (Warsz)</addtitle><description>Introduction Proteus mirabilis bacilli play an important role in human urinary tract infections, bacteremia, and rheumatoid arthritis. The authors previously studied human complement C3 conversion by smooth-form P. mirabilis O10, O23, O30, and O43 lipopolysaccharides (LPSs) and showed that smooth Proteus LPSs fragmented C3 in a dose- and time-dependent manner. In the present study, one smooth P. mirabilis S1959 and its two polysaccharide-truncated LPSs isolated from an R mutant strain were used to study the C3 conversion. Materials and Methods The conversion of C3 to C3c by smooth and rough P. mirabilis LPSs was studied by capture ELISA and crossed immunoelectrophoresis. Proteins isolated from the outer membrane were analyzed by discontinuous sodium dodecyl sulfate gel electrophoresis. Results The smooth P. mirabilis S1959 (O3) strain was resistant to the bactericidal activity of human serum, in contrast to the Ra and Re mutant strains. The presence of an exposed core oligosaccharide in R110 LPS was not sufficient to protect the strain from serum-dependent killing. In addition to LPS structure, the outer-membrane proteins may also play roles in protecting the smooth P. mirabilis S1959 (O3) strain from the bactericidal action of serum. It was shown that the Ra P. mirabilis R110 and the Re P. mirabilis R45 mutants possess very different OMP compositions from that of the P. mirabilis S 1959 strain. Conclusion Regardless of the complement resistance of the P. mirabilis strains, the S1959, R110, and R45 LPSs fragmented C3 and induced C3c neo-antigen exposure. The use of complement-deficient human serum allows the conclusion that the Re-type P. mirabilis R45 LPS fragmented C3 by the antibody-independent classical pathway.</description><subject>Bacteria</subject><subject>Bacterial Outer Membrane Proteins - immunology</subject><subject>Bacterial Outer Membrane Proteins - isolation &amp; purification</subject><subject>Bacteriology</subject><subject>Basic Medicine</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>complement</subject><subject>Complement Activation - drug effects</subject><subject>Complement Activation - immunology</subject><subject>Complement C3 - immunology</subject><subject>Complement System Proteins - immunology</subject><subject>Humans</subject><subject>Immunologi inom det medicinska området</subject><subject>Immunology</subject><subject>Immunology in the medical area</subject><subject>lipopolysaccharide</subject><subject>Lipopolysaccharides - immunology</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Medical and Health Sciences</subject><subject>Medicin och hälsovetenskap</subject><subject>Medicinska och farmaceutiska grundvetenskaper</subject><subject>Microbial Sensitivity Tests</subject><subject>Microbiology in the medical area</subject><subject>Mikrobiologi inom det medicinska området</subject><subject>Original Article</subject><subject>outer-membrane</subject><subject>outer-membrane protein</subject><subject>Pharmacology/Toxicology</subject><subject>protein</subject><subject>Proteins</subject><subject>Proteus Infections - immunology</subject><subject>Proteus mirabilis</subject><subject>Proteus mirabilis - chemistry</subject><subject>Proteus mirabilis - immunology</subject><subject>Serum - chemistry</subject><subject>Serum - immunology</subject><issn>0004-069X</issn><issn>1661-4917</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp9kV2L1TAQhoMo7tnVH-CNFi-8q07afDSXsqyucEBBD3gXknZ6Tta2qUmrnH9vSssuCJowJGSeeZPMS8gLCm8pgHwXIQ2eA6gUrMyrR2RHhaA5U1Q-JruUZTkI9f2CXMZ4tzCcsqfkgioJUhZ0Rw63c2-GrPb92GGPw5SZenK_zOT8kNlzFnvvp1NmhiYLfj6esi_BTzjHrHfBWNe5mHVu9KPvztHU9ckE12B8Rp60pov4fFuvyOHDzbfr23z_-eOn6_f7vOasnHKlmEgPAmqaRnBRUGgLVQlqsJAgWgOMS0OtZcBbQCkst4BGqJIhty2Y8orkq278jeNs9Rhcb8JZe-P0dvQj7VDzpM5o4vf_5Lt5TGFTLAUNpqtESTW3SDVrS9S24kbz2tYlb0RVNWWSe7PKjcH_nDFOunexxq4zA_o5aiEFCKaqBL7-C7zzcxhSa3QlFVQqtSFBdIXq4GMM2N4_j4Je_Nar3zr5rRcv9SL8chOebY_NQ8VmcAKK7ccpNRwxPNz8P9VXa1FrvDbH4KI-fC2AlkCFLEWafwAcb7-J</recordid><startdate>20091001</startdate><enddate>20091001</enddate><creator>Kaca, Wiesław</creator><creator>Arabski, Michał Ph.D</creator><creator>Fudała, Rafał</creator><creator>Holmström, Eva</creator><creator>Sjöholm, Anders</creator><creator>Weintraub, Andrej</creator><creator>Futoma-Kołoch, Bożena</creator><creator>Bugla-Płoskońska, Gabriela</creator><creator>Doroszkiewicz, Włodzimierz</creator><general>Basel : SP Birkhäuser Verlag Basel</general><general>SP Birkhäuser Verlag Basel</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D95</scope><scope>D8T</scope><scope>ZZAVC</scope></search><sort><creationdate>20091001</creationdate><title>Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides</title><author>Kaca, Wiesław ; Arabski, Michał Ph.D ; Fudała, Rafał ; Holmström, Eva ; Sjöholm, Anders ; Weintraub, Andrej ; Futoma-Kołoch, Bożena ; Bugla-Płoskońska, Gabriela ; Doroszkiewicz, Włodzimierz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c543t-994651401add656210f29861ae2706fa0457a1bb405f0e76b5b0ea6934e5bf0a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Bacteria</topic><topic>Bacterial Outer Membrane Proteins - immunology</topic><topic>Bacterial Outer Membrane Proteins - isolation &amp; purification</topic><topic>Bacteriology</topic><topic>Basic Medicine</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>complement</topic><topic>Complement Activation - drug effects</topic><topic>Complement Activation - immunology</topic><topic>Complement C3 - immunology</topic><topic>Complement System Proteins - immunology</topic><topic>Humans</topic><topic>Immunologi inom det medicinska området</topic><topic>Immunology</topic><topic>Immunology in the medical area</topic><topic>lipopolysaccharide</topic><topic>Lipopolysaccharides - immunology</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Medical and Health Sciences</topic><topic>Medicin och hälsovetenskap</topic><topic>Medicinska och farmaceutiska grundvetenskaper</topic><topic>Microbial Sensitivity Tests</topic><topic>Microbiology in the medical area</topic><topic>Mikrobiologi inom det medicinska området</topic><topic>Original Article</topic><topic>outer-membrane</topic><topic>outer-membrane protein</topic><topic>Pharmacology/Toxicology</topic><topic>protein</topic><topic>Proteins</topic><topic>Proteus Infections - immunology</topic><topic>Proteus mirabilis</topic><topic>Proteus mirabilis - chemistry</topic><topic>Proteus mirabilis - immunology</topic><topic>Serum - chemistry</topic><topic>Serum - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kaca, Wiesław</creatorcontrib><creatorcontrib>Arabski, Michał Ph.D</creatorcontrib><creatorcontrib>Fudała, Rafał</creatorcontrib><creatorcontrib>Holmström, Eva</creatorcontrib><creatorcontrib>Sjöholm, Anders</creatorcontrib><creatorcontrib>Weintraub, Andrej</creatorcontrib><creatorcontrib>Futoma-Kołoch, Bożena</creatorcontrib><creatorcontrib>Bugla-Płoskońska, Gabriela</creatorcontrib><creatorcontrib>Doroszkiewicz, Włodzimierz</creatorcontrib><collection>AGRIS</collection><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection (ProQuest Medical &amp; Health Databases)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Lunds universitet</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><jtitle>Archivum Immunologiae et Therapiae Experimentalis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kaca, Wiesław</au><au>Arabski, Michał Ph.D</au><au>Fudała, Rafał</au><au>Holmström, Eva</au><au>Sjöholm, Anders</au><au>Weintraub, Andrej</au><au>Futoma-Kołoch, Bożena</au><au>Bugla-Płoskońska, Gabriela</au><au>Doroszkiewicz, Włodzimierz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides</atitle><jtitle>Archivum Immunologiae et Therapiae Experimentalis</jtitle><stitle>Arch. Immunol. Ther. Exp</stitle><addtitle>Arch Immunol Ther Exp (Warsz)</addtitle><date>2009-10-01</date><risdate>2009</risdate><volume>57</volume><issue>5</issue><spage>383</spage><epage>391</epage><pages>383-391</pages><issn>0004-069X</issn><eissn>1661-4917</eissn><abstract>Introduction Proteus mirabilis bacilli play an important role in human urinary tract infections, bacteremia, and rheumatoid arthritis. The authors previously studied human complement C3 conversion by smooth-form P. mirabilis O10, O23, O30, and O43 lipopolysaccharides (LPSs) and showed that smooth Proteus LPSs fragmented C3 in a dose- and time-dependent manner. In the present study, one smooth P. mirabilis S1959 and its two polysaccharide-truncated LPSs isolated from an R mutant strain were used to study the C3 conversion. Materials and Methods The conversion of C3 to C3c by smooth and rough P. mirabilis LPSs was studied by capture ELISA and crossed immunoelectrophoresis. Proteins isolated from the outer membrane were analyzed by discontinuous sodium dodecyl sulfate gel electrophoresis. Results The smooth P. mirabilis S1959 (O3) strain was resistant to the bactericidal activity of human serum, in contrast to the Ra and Re mutant strains. The presence of an exposed core oligosaccharide in R110 LPS was not sufficient to protect the strain from serum-dependent killing. In addition to LPS structure, the outer-membrane proteins may also play roles in protecting the smooth P. mirabilis S1959 (O3) strain from the bactericidal action of serum. It was shown that the Ra P. mirabilis R110 and the Re P. mirabilis R45 mutants possess very different OMP compositions from that of the P. mirabilis S 1959 strain. Conclusion Regardless of the complement resistance of the P. mirabilis strains, the S1959, R110, and R45 LPSs fragmented C3 and induced C3c neo-antigen exposure. The use of complement-deficient human serum allows the conclusion that the Re-type P. mirabilis R45 LPS fragmented C3 by the antibody-independent classical pathway.</abstract><cop>Basel</cop><pub>Basel : SP Birkhäuser Verlag Basel</pub><pmid>19707721</pmid><doi>10.1007/s00005-009-0043-8</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0004-069X
ispartof Archivum Immunologiae et Therapiae Experimentalis, 2009-10, Vol.57 (5), p.383-391
issn 0004-069X
1661-4917
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_556241
source Springer Link
subjects Bacteria
Bacterial Outer Membrane Proteins - immunology
Bacterial Outer Membrane Proteins - isolation & purification
Bacteriology
Basic Medicine
Biomedical and Life Sciences
Biomedicine
complement
Complement Activation - drug effects
Complement Activation - immunology
Complement C3 - immunology
Complement System Proteins - immunology
Humans
Immunologi inom det medicinska området
Immunology
Immunology in the medical area
lipopolysaccharide
Lipopolysaccharides - immunology
Lipopolysaccharides - pharmacology
Medical and Health Sciences
Medicin och hälsovetenskap
Medicinska och farmaceutiska grundvetenskaper
Microbial Sensitivity Tests
Microbiology in the medical area
Mikrobiologi inom det medicinska området
Original Article
outer-membrane
outer-membrane protein
Pharmacology/Toxicology
protein
Proteins
Proteus Infections - immunology
Proteus mirabilis
Proteus mirabilis - chemistry
Proteus mirabilis - immunology
Serum - chemistry
Serum - immunology
title Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T09%3A42%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20complement%20activation%20by%20smooth%20and%20rough%20Proteus%20mirabilis%20lipopolysaccharides&rft.jtitle=Archivum%20Immunologiae%20et%20Therapiae%20Experimentalis&rft.au=Kaca,%20Wies%C5%82aw&rft.date=2009-10-01&rft.volume=57&rft.issue=5&rft.spage=383&rft.epage=391&rft.pages=383-391&rft.issn=0004-069X&rft.eissn=1661-4917&rft_id=info:doi/10.1007/s00005-009-0043-8&rft_dat=%3Cproquest_swepu%3E67606498%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c543t-994651401add656210f29861ae2706fa0457a1bb405f0e76b5b0ea6934e5bf0a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=879089651&rft_id=info:pmid/19707721&rfr_iscdi=true